{"id":"tp-59526","type":"article-newspaper","title":"EU Approves Incyte's Povofortay for Adults With Limited Anti-TNF Options","author":"Riza Dagoc","publisher":"TOKENPOST Inc.","url":"https://www.tokenpost.com/news/regulation/59526","datePublished":"2026-11-17T15:11:26.000Z","dateModified":"2026-11-17T15:11:26.000Z","language":"en","abstract":"The authorization covers active moderate to severe hidradenitis suppurativa. U.S. regulators are reviewing an application for the same drug.","section":"Regulation","references":[]}